Tag: Novo Nordisk A/S

Here’s our monthly update on all 31 portfolio stocks, including 3 on the buy list

Novo Nordisk partners with OpenAI as AI drug discovery hopes mount 

As millions lose weight on GLP-1s, they’re starting to turn to retailers to refresh their wardrobes

Novo Nordisk’s explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment

Trump tariff fallout: Some industries grapple with lingering effects one year later

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison

FDA approves Eli Lilly’s GLP-1 pill, opening the next phase of the weight loss drug market

Stocks soar on hopes of Iran war resolution — plus, Lilly takes a big swing in sleep disorders

Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to catch up with Eli Lilly